Generic drug-maker Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) is shutting a recently acquired Montreal-area plant, putting 340 people out of work. The Israeli generic drug giant acquired the plant last year when it purchased Germany’s Ratiopharm; Teva had already announced plans to either sell the plant in Mirabel, Que., within a certain deadline, or shut it down. A news release from the union representing Teva workers says they were provided details Tuesday of plans for the shutdown.
